The U.S. Centers for Disease Control and Prevention expects COVID-19 vaccine boosters targeting circulating variants of the virus to be available for children aged 5-11 years by mid-October.
U.S. President Joe Biden said in an interview aired on Sunday that “the pandemic is over,” even though the country continues to grapple with coronavirus infections that kill hundreds of Americans daily.
U.S. Centers of Disease Control and Prevention (CDC) Director Rochelle Walensky said on Thursday she was cautiously optimistic over a decline in the growth of new monkeypox cases, but that some areas of the country are still experiencing a rise in infections.
The Los Angeles Department of Public Health said on Monday it had confirmed the area’s first death due to monkeypox, saying the individual was severely immunocompromised and had been hospitalized.
The United States is likely to start recommending COVID-19 vaccines annually, health officials said on Tuesday, as new boosters designed to fight currently circulating variants of the coronavirus roll out.
New COVID-19 boosters aimed at fighting currently circulating variants of the coronavirus will be widely available this week, U.S. health officials said on Tuesday, adding that the vaccine is moving closer to an annual jab, as with flu shots.
The U.S. Centers for Disease Control and Prevention (CDC) on Thursday recommended the use of redesigned COVID-19 booster shots for people aged 12 years and older to target the BA.4 and BA.5 Omicron subvariants of the coronavirus.
Life expectancy fell in the United States in 2021 to its lowest since 1996, the second year of a historic retreat due to COVID-19 deaths, provisional government data showed on Wednesday.
Texas on Tuesday reported the first death in a severely immunocompromised person who was diagnosed with monkeypox, according to state health department officials.
Most doses of Bavarian Nordic’s two-dose Jynneos monkeypox vaccine administered in the United States have been first doses, U.S. Centers for Disease Control and Prevention Director Rochelle Walensky said on Friday.